论文部分内容阅读
肾移植后红细胞增多症（ＰＴＥ）是肾移植后一种较为常见的并发症，为探讨其治疗方法，分别以氨茶碱、地尔硫、依那普利来治疗ＰＴＥ患者。发现氨茶碱能明显降低ＰＴＥ患者的血红蛋白（Ｈｂ）及红细胞压积（ＨＣＴ），该作用与促红细胞生成素降低有关，其缺点是停用后可复发，但继续服用仍有效。依那普利不但能显著降低Ｈｂ及ＨＣＴ，还可治疗难治性高血压，适用于伴有高血压的ＰＴＥ患者；地尔硫对ＰＴＥ的治疗作用不大。认为ＰＴＥ虽属自限性疾病，但恰当的药物治疗是必需的。
Post-renal transplantation polycythemia (PTE) is a more common complication after renal transplantation, in order to explore its treatment, respectively, aminophylline, diltiazem, enalapril to treat PTE patients. Found that aminophylline can significantly reduce hemoglobin (Hb) and hematocrit (HCT) in patients with PTE, the role of erythropoietin and reduced the shortcomings of relapse after discontinuation, but still continue to take effective. Enalapril can not only significantly reduce Hb and HCT, but also treat refractory hypertension, which is suitable for patients with PTE accompanied by hypertension. Diltiazem has little effect on the treatment of PTE. Although PTE is a self-limiting disease, proper medical treatment is required.